A trend in acquired drug resistances of tuberculosis patients registered in health centers from 1981 to 2004

Chulhun L. Chang, Eun Yup Lee, Soon Kew Park, Seokhoon Jeong, Young Kil Park, Yong Woon Choi, Hee Jin Kim, Woo Jin Lew, Gill Han Bai

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: The drug resistance rate in tuberculosis patients with history of chemotherapy is an important indicator of for evaluation of appropriateness of treatment regimens and compliance of patients. This study examined the long-term changes in the drug resistance rates among TB patients failed in treatment or reactivated. Methods: The results of drug susceptibility testing data from patients registered in health centers from 1981 to 2004 were analyzed Results: The rate of resistance to isoniazid decreased from 90% to 20%, and the resistance to ethambutol decreased from 45% to 6%. The rate of resistance to rifampicin varied from 13% to 28% and the resistance to pyrazinamide was 5% to 10%. Multidrug resistance was about 2-3% lower than any rifampicin resistance rates. The second-line drug resistance was ranged from 1% to 3%. There was no difference between patients' genders. Patient numbers per 100,000 population increased with age. The regional distribution was even at 4-6 patients per 100,000 population, and drug resistance rates were significantly lower in big city areas than in small towns and rural areas. Conclusion: The rates of resistance of Mycobacterium tuberculosis isolated from TB patients with history of chemotherapy to isoniazid, rifampin, ethambutol, and isoniazid plus rifampin were significantly decreased during over two decades.

Original languageEnglish
Pages (from-to)619-624
Number of pages6
JournalTuberculosis and Respiratory Diseases
Volume59
Issue number6
DOIs
Publication statusPublished - 2005 Jan 1

Fingerprint

Drug Resistance
Tuberculosis
Rifampin
Health
Isoniazid
Ethambutol
Pyrazinamide
Drug Therapy
Multiple Drug Resistance
Patient Compliance
Mycobacterium tuberculosis
Population
Therapeutics
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Infectious Diseases

Cite this

Chang, Chulhun L. ; Lee, Eun Yup ; Park, Soon Kew ; Jeong, Seokhoon ; Park, Young Kil ; Choi, Yong Woon ; Kim, Hee Jin ; Lew, Woo Jin ; Bai, Gill Han. / A trend in acquired drug resistances of tuberculosis patients registered in health centers from 1981 to 2004. In: Tuberculosis and Respiratory Diseases. 2005 ; Vol. 59, No. 6. pp. 619-624.
@article{98e3dc5d6d9b429abf1e7feea5cec351,
title = "A trend in acquired drug resistances of tuberculosis patients registered in health centers from 1981 to 2004",
abstract = "Background: The drug resistance rate in tuberculosis patients with history of chemotherapy is an important indicator of for evaluation of appropriateness of treatment regimens and compliance of patients. This study examined the long-term changes in the drug resistance rates among TB patients failed in treatment or reactivated. Methods: The results of drug susceptibility testing data from patients registered in health centers from 1981 to 2004 were analyzed Results: The rate of resistance to isoniazid decreased from 90{\%} to 20{\%}, and the resistance to ethambutol decreased from 45{\%} to 6{\%}. The rate of resistance to rifampicin varied from 13{\%} to 28{\%} and the resistance to pyrazinamide was 5{\%} to 10{\%}. Multidrug resistance was about 2-3{\%} lower than any rifampicin resistance rates. The second-line drug resistance was ranged from 1{\%} to 3{\%}. There was no difference between patients' genders. Patient numbers per 100,000 population increased with age. The regional distribution was even at 4-6 patients per 100,000 population, and drug resistance rates were significantly lower in big city areas than in small towns and rural areas. Conclusion: The rates of resistance of Mycobacterium tuberculosis isolated from TB patients with history of chemotherapy to isoniazid, rifampin, ethambutol, and isoniazid plus rifampin were significantly decreased during over two decades.",
author = "Chang, {Chulhun L.} and Lee, {Eun Yup} and Park, {Soon Kew} and Seokhoon Jeong and Park, {Young Kil} and Choi, {Yong Woon} and Kim, {Hee Jin} and Lew, {Woo Jin} and Bai, {Gill Han}",
year = "2005",
month = "1",
day = "1",
doi = "10.4046/trd.2005.59.6.619",
language = "English",
volume = "59",
pages = "619--624",
journal = "Tuberculosis and Respiratory Diseases",
issn = "1738-3536",
publisher = "The Korean Academy of Tuberculosis and Respiratory Diseases",
number = "6",

}

A trend in acquired drug resistances of tuberculosis patients registered in health centers from 1981 to 2004. / Chang, Chulhun L.; Lee, Eun Yup; Park, Soon Kew; Jeong, Seokhoon; Park, Young Kil; Choi, Yong Woon; Kim, Hee Jin; Lew, Woo Jin; Bai, Gill Han.

In: Tuberculosis and Respiratory Diseases, Vol. 59, No. 6, 01.01.2005, p. 619-624.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A trend in acquired drug resistances of tuberculosis patients registered in health centers from 1981 to 2004

AU - Chang, Chulhun L.

AU - Lee, Eun Yup

AU - Park, Soon Kew

AU - Jeong, Seokhoon

AU - Park, Young Kil

AU - Choi, Yong Woon

AU - Kim, Hee Jin

AU - Lew, Woo Jin

AU - Bai, Gill Han

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Background: The drug resistance rate in tuberculosis patients with history of chemotherapy is an important indicator of for evaluation of appropriateness of treatment regimens and compliance of patients. This study examined the long-term changes in the drug resistance rates among TB patients failed in treatment or reactivated. Methods: The results of drug susceptibility testing data from patients registered in health centers from 1981 to 2004 were analyzed Results: The rate of resistance to isoniazid decreased from 90% to 20%, and the resistance to ethambutol decreased from 45% to 6%. The rate of resistance to rifampicin varied from 13% to 28% and the resistance to pyrazinamide was 5% to 10%. Multidrug resistance was about 2-3% lower than any rifampicin resistance rates. The second-line drug resistance was ranged from 1% to 3%. There was no difference between patients' genders. Patient numbers per 100,000 population increased with age. The regional distribution was even at 4-6 patients per 100,000 population, and drug resistance rates were significantly lower in big city areas than in small towns and rural areas. Conclusion: The rates of resistance of Mycobacterium tuberculosis isolated from TB patients with history of chemotherapy to isoniazid, rifampin, ethambutol, and isoniazid plus rifampin were significantly decreased during over two decades.

AB - Background: The drug resistance rate in tuberculosis patients with history of chemotherapy is an important indicator of for evaluation of appropriateness of treatment regimens and compliance of patients. This study examined the long-term changes in the drug resistance rates among TB patients failed in treatment or reactivated. Methods: The results of drug susceptibility testing data from patients registered in health centers from 1981 to 2004 were analyzed Results: The rate of resistance to isoniazid decreased from 90% to 20%, and the resistance to ethambutol decreased from 45% to 6%. The rate of resistance to rifampicin varied from 13% to 28% and the resistance to pyrazinamide was 5% to 10%. Multidrug resistance was about 2-3% lower than any rifampicin resistance rates. The second-line drug resistance was ranged from 1% to 3%. There was no difference between patients' genders. Patient numbers per 100,000 population increased with age. The regional distribution was even at 4-6 patients per 100,000 population, and drug resistance rates were significantly lower in big city areas than in small towns and rural areas. Conclusion: The rates of resistance of Mycobacterium tuberculosis isolated from TB patients with history of chemotherapy to isoniazid, rifampin, ethambutol, and isoniazid plus rifampin were significantly decreased during over two decades.

UR - http://www.scopus.com/inward/record.url?scp=33644691599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644691599&partnerID=8YFLogxK

U2 - 10.4046/trd.2005.59.6.619

DO - 10.4046/trd.2005.59.6.619

M3 - Article

AN - SCOPUS:33644691599

VL - 59

SP - 619

EP - 624

JO - Tuberculosis and Respiratory Diseases

JF - Tuberculosis and Respiratory Diseases

SN - 1738-3536

IS - 6

ER -